A Phase 2 Study to Evaluate the Efficacy and Safety of Pudafensine in Vulvodynia (Provoked Vestibulodynia)
Clinical trial NCT07391241 · RECRUITING
Trial details
- NCT number
- NCT07391241
- Sponsor
- Initiator Pharma
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-17
- Primary completion
- 2026-09-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.